CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial

Table 4 Adjustment of cefazolin doses according to renal function

GFR	Cefazolin dose
>40 ml/min	2 g q8h IVI
21–40 ml/min	1 g q8h IVI
≤20 but not on haemodialysis	1 g q12h IVI
On continuous renal replacement therapy	2 g q12h IVI
On haemodialysis	2 g 3x/week post dialysis

ISSN: 1745-6215